Related Experiment Video
Updated: Aug 9, 2026
10:05
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Avoiding psychotropic drug interactions in the cardiovascular patient
1Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston 49425, USA.
Bulletin of the Menninger Clinic
|March 1, 2000
Summary
Newer antidepressants can interact with cardiovascular drugs due to their effects on liver enzymes. Psychiatrists must be aware of these potential drug interactions to ensure safe prescribing for patients with comorbid mental and cardiovascular conditions.
Area of Science:
- Pharmacology
- Psychiatry
- Cardiology
Background:
- Growing use of newer antidepressants.
- Hepatic cytochrome P450 enzymes are crucial for drug metabolism.
- Potential for drug-drug interactions (DDIs) between antidepressants and cardiovascular medications.
Purpose of the Study:
- To summarize potential DDIs between psychoactive drugs and cardiovascular medications.
- To increase awareness among psychiatrists regarding these interactions.
- To improve prescribing practices for patients with comorbid cardiovascular disease and mental disorders.
Main Methods:
- Literature review and summary of existing data.
- Focus on hepatic cytochrome P450 inhibitory effects.
- Analysis of potential interactions relevant to psychiatric practice.
Main Results:
- Newer antidepressants exhibit varying degrees of cytochrome P450 inhibition.
- Significant potential for DDIs exists, impacting cardiovascular drug efficacy and safety.
- Identification of specific antidepressant-cardiovascular drug pairs requiring caution.
Conclusions:
- Awareness of DDIs is critical for psychiatrists.
- Knowledge of these interactions enhances patient safety.
- Informed prescribing improves management of comorbid conditions.
Related Concept Videos
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications